Inhibition of polo-like kinase 1 (PLK1) additively improves outcome of ionising irradiation (IR) in colorectal cancer (CRC)Weng Ng, C.S. Lee, B. Wang et al.|Pathology|2017Cited by 1
KRAS AND BRAF mutation rates and survival outcomes in colorectal cancer in an ethnically-diverse cohortPaul Habashy, C.S. Lee, Kate Wilkinson et al.|Pathology|2021Cited by 0